Biotech

TiGenix Appoints Jean Stephenne Chairman & Russell Greig Member of Board of Directors

LEUVEN, BELGIUM: ...

Lifebank and Insception Confirm Offered Consideration of $0.495 per Lifebank Common Share

BURNABY, BRITISH COLUMBIA and TORONTO, ONTARIO: ...

Threshold Pharmaceuticals Announces Presentation and Webcast at BIOX, Noble Financial Capital Markets' Life Sciences Exposition

SOUTH SAN FRANCISCO, CA: ...

Critical Outcome Technologies Inc. Initiates Final Toxicity Studies for COTI-2

LONDON, ONTARIO: Last Major Experiments in Preparing for Human Trial Submission ...

Phrixus Pharmaceuticals, Inc. Receives Notice of Allowance for Additional U.S. Patent on Carmeseal(TM) (Poloxamer-188)

ANN ARBOR, MI: Expands Exclusivity for Carmeseal(TM), a First-in-Class, Subcutaneously-Administered Investigational Drug for Duchenne Muscular Dystrophy and Acute Decompensated Heart Failure ...

Functional Technologies Announces Internal Promotion of Chief Technology and Innovations Officer and Board Changes

VANCOUVER, BRITISH COLUMBIA: ...

Manuscripts Describing Novel CYP2C9 and MRP2 Humanized Mouse Models Accepted for Publication by Two Prestigious Scientific Journals

HUDSON, NY: ...

Cornerstone Therapeutics Provides Update on FDA Advisory Committee Discussion of Lixivaptan

CARY, NC: FDA Advisory Committee Voted Against Approval of Lixivaptan for the Treatment of Hyponatremia ...

Sarepta Therapeutics to Present Company Overview at the 2012 UBS Global Life Sciences Conference

CAMBRIDGE, MA: Webcast Accessible via Sarepta Therapeutics Website ...

No Placebo Effect Needed as Life Science Sector Wraps $3.3 Billion in Project Investments in Third-Quarter 2012, an Industrial Info News Alert

SUGAR LAND, TX: ...